×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CELC – celcuity inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CELC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/2
08:04 am
celc
Celcuity (NASDAQ:CELC) had its price target raised by analysts at Jefferies Financial Group Inc. from $108.00 to $134.00. They now have a "buy" rating on the stock.
Low
Report
Celcuity (NASDAQ:CELC) had its price target raised by analysts at Jefferies Financial Group Inc. from $108.00 to $134.00. They now have a "buy" rating on the stock.
11/28
11:26 pm
celc
Celcuity (CELC): Assessing Valuation Following Recent Share Price Surge [Yahoo! Finance]
Low
Report
Celcuity (CELC): Assessing Valuation Following Recent Share Price Surge [Yahoo! Finance]
11/28
07:33 am
celc
Celcuity: From Speculative Bet To Pre-Commercial Powerhouse [Seeking Alpha]
Low
Report
Celcuity: From Speculative Bet To Pre-Commercial Powerhouse [Seeking Alpha]
11/27
05:44 pm
celc
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results [Yahoo! Finance]
Low
Report
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results [Yahoo! Finance]
11/26
05:38 pm
celc
Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium [Yahoo! Finance]
Low
Report
Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium [Yahoo! Finance]
11/26
04:05 pm
celc
Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium
Low
Report
Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium
11/26
07:13 am
celc
Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
Low
Report
Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
11/26
07:05 am
celc
Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference
Low
Report
Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/3
04:10 pm
celc
Form 4 Celcuity Inc. For: Dec 01 Filed by: Buller Richard E
Medium
Report
Form 4 Celcuity Inc. For: Dec 01 Filed by: Buller Richard E
12/1
05:46 pm
celc
Form 144 Celcuity Inc. Filed by: Buller Richard E
Low
Report
Form 144 Celcuity Inc. Filed by: Buller Richard E
11/24
04:07 pm
celc
Form 4 Celcuity Inc. For: Nov 21 Filed by: Dalvey David
Low
Report
Form 4 Celcuity Inc. For: Nov 21 Filed by: Dalvey David
11/21
04:14 pm
celc
Form 4 Celcuity Inc. For: Nov 19 Filed by: Buller Richard E
Medium
Report
Form 4 Celcuity Inc. For: Nov 19 Filed by: Buller Richard E
11/21
01:42 pm
celc
Form 144 Celcuity Inc. Filed by: Dalvey David
Low
Report
Form 144 Celcuity Inc. Filed by: Dalvey David
11/20
04:34 pm
celc
Form 144 Celcuity Inc. Filed by: Buller Richard E
Medium
Report
Form 144 Celcuity Inc. Filed by: Buller Richard E
11/17
04:36 pm
celc
Form 8-K Celcuity Inc. For: Nov 17
Medium
Report
Form 8-K Celcuity Inc. For: Nov 17
11/14
04:08 pm
celc
Form SCHEDULE 13G/A Celcuity Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
Low
Report
Form SCHEDULE 13G/A Celcuity Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/18
Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.
7.9%
4/23 Celcuity Inc. Schedules Release of First Quarter 2020 Financial Results and Conference Call 7.6%
5/8 Celcuity Inc (NASDAQ: CELC) was given a new $36.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 3.2%
7/9 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 2.8%
5/20 Celcuity Announces Appointment of Leo Furcht to Board of Directors 2.1%
11/7 Q3/2019 9/30/2019 EPS -0.160 ZacksConsensus -0.180 ActVsEst 0.020 - Beat 1.9%
8/8 Celcuity Reports Second Quarter 2019 Financial Results 1.6%
1/13 Celcuity Inc (NASDAQ: CELC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 1.5%
2/24 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 1.5%
5/20 Form 4 Celcuity Inc. For: May 16 Filed by: NIGON RICHARD 1.4%
4/23 Celcuity Inc. Schedules Release of First Quarter 2020 Financial Results and Conference Call 7.6%
5/8 Celcuity Inc (NASDAQ: CELC) was given a new $36.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 3.2%
7/9 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 2.8%
5/20 Celcuity Announces Appointment of Leo Furcht to Board of Directors 2.1%
11/7 Q3/2019 9/30/2019 EPS -0.160 ZacksConsensus -0.180 ActVsEst 0.020 - Beat 1.9%
8/8 Celcuity Reports Second Quarter 2019 Financial Results 1.6%
1/13 Celcuity Inc (NASDAQ: CELC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 1.5%
2/24 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 1.5%
5/20 Form 4 Celcuity Inc. For: May 16 Filed by: NIGON RICHARD 1.4%
TOP News Decliners
2/14
Form SC 13G/A Celcuity Inc. Filed by: Sullivan Brian F.
-5.1%
8/1 Celcuity Inc (NASDAQ: CELC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $25.00 price target on the stock. -4.3%
3/13 Celcuity Inc (NASDAQ: CELC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock, down previously from $36.00. -3.6%
10/9 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.3%
8/10 Celcuity's (CELC) CEO Brian Sullivan on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -1.9%
11/20 Celcuity Inc (NASDAQ: CELC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -1.1%
7/25 Celcuity Inc. Schedules Release of Second Quarter 2019 Financial Results and Conference Call -1.1%
12/11 Celcuity Presents Results at the 2019 San Antonio Breast Cancer Symposium Evaluating a Sub-Group of PIK3CA WT Breast Cancer Patients Who Have Hyperactive Signaling Tumors Responsive to PI3K Inhibitors -0.9%
11/11 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -0.8%
2/27 Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2019 Financial Results and Conference Call -0.7%
8/1 Celcuity Inc (NASDAQ: CELC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $25.00 price target on the stock. -4.3%
3/13 Celcuity Inc (NASDAQ: CELC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock, down previously from $36.00. -3.6%
10/9 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.3%
8/10 Celcuity's (CELC) CEO Brian Sullivan on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -1.9%
11/20 Celcuity Inc (NASDAQ: CELC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -1.1%
7/25 Celcuity Inc. Schedules Release of Second Quarter 2019 Financial Results and Conference Call -1.1%
12/11 Celcuity Presents Results at the 2019 San Antonio Breast Cancer Symposium Evaluating a Sub-Group of PIK3CA WT Breast Cancer Patients Who Have Hyperactive Signaling Tumors Responsive to PI3K Inhibitors -0.9%
11/11 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -0.8%
2/27 Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2019 Financial Results and Conference Call -0.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: